Antiviral immunity is impaired in COPD patients with frequent exacerbations.

Saved in:
Bibliographic Details
Title: Antiviral immunity is impaired in COPD patients with frequent exacerbations.
Authors: Singanayagam A; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Loo SL; Faculty of Health and Medicine and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, New South Wales, Australia., Calderazzo M; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Finney LJ; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Trujillo Torralbo MB; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Bakhsoliani E; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Girkin J; Faculty of Health and Medicine and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, New South Wales, Australia., Veerati P; Faculty of Health and Medicine and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, New South Wales, Australia., Pathinayake PS; Faculty of Health and Medicine and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, New South Wales, Australia., Nichol KS; Faculty of Health and Medicine and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, New South Wales, Australia., Reid A; Faculty of Health and Medicine and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, New South Wales, Australia., Footitt J; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Wark PAB; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Faculty of Health and Medicine and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, New South Wales, Australia., Grainge CL; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Johnston SL; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Bartlett NW; Faculty of Health and Medicine and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, New South Wales, Australia., Mallia P; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Source: American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2019 Dec 01; Vol. 317 (6), pp. L893-L903. Date of Electronic Publication: 2019 Sep 12.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901229 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-1504 (Electronic) Linking ISSN: 10400605 NLM ISO Abbreviation: Am J Physiol Lung Cell Mol Physiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1522-1504
DOI:10.1152/ajplung.00253.2019